Karl L Prado - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Karl L Prado

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Health Physics|November 27, 2013

The ability of filgrastim to mitigate mortality following LD50/60 total-body irradiation is administration time-dependentAnn M Farese, Cassandra R Brown, Cassandra P Smith, et al.

Radiation Research|June 3, 2015

Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman PrimatesKim G Hankey, Ann M Farese, Erica C Blaauw, et al.

International Journal of Radiation Oncology, Biology, Physics|January 17, 2012

Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancerRomaine C Nichols, Soon N Huh, Karl L Prado, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Health Physics|November 27, 2013

The ability of filgrastim to mitigate mortality following LD50/60 total-body irradiation is administration time-dependentAnn M Farese, Cassandra R Brown, Cassandra P Smith, et al.

Radiation Research|June 3, 2015

Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman PrimatesKim G Hankey, Ann M Farese, Erica C Blaauw, et al.

International Journal of Radiation Oncology, Biology, Physics|January 17, 2012

Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancerRomaine C Nichols, Soon N Huh, Karl L Prado, et al.

Pageof 2